FDA Roundup: August 16, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-16-2024
FDA Marketing Authorization Enables Increased Access to First Step of Syphilis Diagnosis
http://www.fda.gov/news-events/press-announcements/fda-marketing-authorization-enables-increased-access-first-step-syphilis-diagnosis
FDA Issues Warning Letter to Austrofood and Continues Robust Activities to Ensure Safety of Cinnamon Products Sold in U.S.
http://www.fda.gov/news-events/press-announcements/fda-issues-warning-letter-austrofood-and-continues-robust-activities-ensure-safety-cinnamon-products
FDA Announces Milestone in Sodium Reduction Efforts, Issues Draft Guidance with Lower Target Levels for Certain Foods
http://www.fda.gov/news-events/press-announcements/fda-announces-milestone-sodium-reduction-efforts-issues-draft-guidance-lower-target-levels-certain
FDA Roundup: August 13, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-13-2024
US Marshals seize dietary supplements containing kratom
http://www.fda.gov/news-events/press-announcements/us-marshals-seize-dietary-supplements-containing-kratom
Maine smoked fish company agrees to halt production of adulterated fish
http://www.fda.gov/news-events/press-announcements/maine-smoked-fish-company-agrees-halt-production-adulterated-fish
FDA Roundup: August 9, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2024
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nasal-spray-treatment-anaphylaxis
FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose
http://www.fda.gov/news-events/press-announcements/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose
